Federal contract award
W81XWH22F0118
NEW LITES ORDER TASK ORDER 0010 CAVALIER TRIAL
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DEFENSE HEALTH AGENCY |
| NAICS | 541712 |
| PSC | AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | W81XWH16D0024 |
| Set-aside | Not reported |
| Pricing type | COST NO FEE |
| Obligations | $12.0M |
| Current contract value | $12.0M |
| Potential contract value / ceiling | $12.0M |
| Start date | Sep 22, 2022 |
| Current end date | Sep 22, 2026 |
| Potential end date | Sep 22, 2026 |
| Latest award activity | May 19, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 19, 2026 | P00003 | $0 | CALCIUM AND VASOPRESSIN FOLLOWING INJURY EARLY RESUSCITATION CLINICAL TRIAL |
| Feb 2, 2024 | P00002 | $0 | CAVALIER TRIAL |
| Dec 27, 2022 | P00001 | $4.0M | CORRECT CONTRACTOR NAME. ADD INCREMENTAL FUNDS. PER SECTION 711 OF THE 2019 NDAA, USAMRAA TRANSFERRED TO DHA 10/01/2022. |
| Sep 18, 2022 | 0 | $8.0M | NEW LITES ORDER TASK ORDER 0010 CAVALIER TRIAL |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.